ACUITY X4 Connector Tool (Model 4625); RELIANCE 4-FRONT Suture Sleeve (aka Lead Stabilizer) (Model 6403); Lead Cap Kit
Boston Scientific · Decision date May 15, 2026
What did the FDA decide?
FDA records P910073/S190 as a supplement to PMA P910073, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated May 15, 2026.
FDA approval order statement
to change sites for ethylene oxide (EO) gas sterilization operations and final packaging activities for the Accessories used with the Cardiac Rhythm Management (CRM) divisions Pulse Generators and Leads.
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- May 15, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P910073/S190
- Regulatory pathway
- PMA supplement
- Applicant
- Boston Scientific
- Product code
- LWS
- Decision code
- OK30
- Decision date
- May 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implantable cardioverter defibrillator (non-CRT).
- Applicant
- Boston Scientific
- Product code
- LWS
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P910073. Subsequent supplements may change the device or its indications.
FDA decision timeline
P910073 · Original PMA
ENDOTAK LEAD SYSTEM
P910073/S176 · Related supplement
ENDOTAK RELIANCE S, ENDOTAK RELIANCE, ENDOTAK RELIANCE SG, ENDOTAK RELIANCE G, RELIANCE 4-FRONT
P910073/S183 · Related supplement
ACC SUP CONNECTOR QUAD PSA TO IS4; ACC SUP SUTURE SLEEVE; ACC SUP KIT LD CAP; STRL PKG LEAD REPAIR KIT; ACC STY STR .016
P910073/S182 · Related supplement
ENDOTAK RELIANCE Leads
P910073/S186 · Related supplement
RELIANCE 4-FRONT/model 0636; RELIANCE 4-FRONT/ model 0662; RELIANCE 4-FRONT/ model 0663 00802526592805 P910073; RELIANC
P910073/S185 · Related supplement
ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leads
P910073/S187 · Related supplement
ENDOTAK RELIANCE / RELIANCE 4-FRONT pace/sense defibrillation leads
P910073/S188 · Related supplement
ACUITY X4 Connector Tool Model 4625 AICD Lead Stylets Firm Model 6971 AICD Lead Stylets Soft Model 6972 Suture S
P910073/S190 received
Application receipt date recorded by FDA.
P910073/S189 · Related supplement
RELIANCE S Active Fix Single Coil IS-1/DF-1 59cm (Model 0137); RELIANCE S Active Fix Single Coil IS-1/DF-1 64cm (Model 0
P910073/S190 · FDA decision
30-Day Notice
P910073/S191 · Related supplement
Endotak Reliance Leads (0128, 0137, 0138, 0147, 0148, 0157, 0158); Endotak Reliance 4-Site Leads (0262, 0263, 0265, 0266
P910073/S192 · Related supplement
RELIANCE S Passive Single Coil, RELIANCE S Active Fix Single Coil, RELIANCE Passive Dual Coil, RELIANCE Active Fix Dual
P910073/S193 · Related supplement
ENDOTAK LEAD SYSTEM
Timeline entries are records held by MedtechLedger for P910073. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P910073
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ENDOTAK LEAD SYSTEMP910073 | Boston Scientific | PMA approval | Aug 26, 1993 | FDA |
| Boston Scientific | PMA supplement | Aug 22, 2025 | FDA | |
| Boston Scientific | PMA supplement | Sep 16, 2025 | FDA | |
ENDOTAK RELIANCE LeadsP910073/S182 | Boston Scientific | PMA supplement | Oct 24, 2025 | FDA |
| Boston Scientific | PMA supplement | Feb 13, 2026 | FDA | |
| Boston Scientific | PMA supplement | Feb 20, 2026 | FDA | |
| Boston Scientific | PMA supplement | Mar 6, 2026 | FDA | |
| Boston Scientific | PMA supplement | Apr 10, 2026 | FDA | |
| Boston Scientific | PMA supplement | Apr 22, 2026 | FDA | |
| Boston Scientific | PMA supplement | Jun 3, 2026 | FDA | |
| Boston Scientific | PMA supplement | Jun 9, 2026 | FDA | |
ENDOTAK LEAD SYSTEMP910073/S193 | Boston Scientific | PMA supplement | Sep 17, 2026 | FDA |
Explore the linked device profile
Other records with product code LWS
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Nov 5, 2026 | FDA | |
| Medtronic Cardiac Rhythm Disease Management | PMA supplement | Nov 4, 2026 | FDA | |
Cobalt MRI ICD, Cobalt XT MRI ICD, Crome MRI ICDP980016/S967 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 29, 2026 | FDA |
| Biotronik, Inc. | PMA supplement | Oct 22, 2026 | FDA | |
| Biotronik, Inc. | PMA supplement | Oct 13, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 4100 Hamline Ave. N, St Paul, MN, 55112
Sources and methodology
- Original FDA record: P910073/S190
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records





